Clear market notes built around the JSE, the rand, and what matters locally.

2026-07-20 07:15 • The Motley Fool Positive Axe Cap view: Selective

Pfizer is positioning itself as a contender in the rapidly growing $100 billion weight-loss drug market through its acquisition of Metsera and development of promising GLP-1 candidates like MET-097i, which showed strong efficacy with potential monthly dosing. However, the company faces stiff competition from Eli Lilly and Novo Nordisk, who currently lead the market with more advanced triple agonist drugs. While Pfizer may not dominate the space, it is well-positioned to be a significant player, and the company has other growth drivers including oncology pipeline and a high dividend yield of 6.9%.

Axe note: Pfizer’s growing appetite in weight-loss drugs adds a new dimension to its diversified JSE-friendly profile.

2026-07-20 07:05 • The Motley Fool Positive Axe Cap view: Selective

Berkshire Hathaway's exit from Mastercard doesn't necessarily indicate the business has weakened. The sale likely reflects opportunity cost considerations, as Berkshire tripled its Alphabet investment during the same period. For long-term investors, the key question is whether Mastercard's fundamentals have deteriorated, not whether to blindly follow Berkshire's portfolio moves. Mastercard remains a high-quality business with strong margins, capital-light operations, and exposure to digital payment growth.

Axe note: Berkshire’s sale of Mastercard shares reflects capital reallocation, not a deterioration in Mastercard’s strong fundamentals.

2026-07-20 06:30 • The Motley Fool Neutral Axe Cap view: Neutral

Warren Buffett announced he will donate his entire $140 billion Berkshire Hathaway stake to charity by December 31, 2034. He recently donated $5.96 billion worth of shares and still owns approximately $140.25 billion in Class A shares. The article notes this philanthropic move should not significantly impact Berkshire's stock price, as it represents a transfer rather than a sale, and shareholders should focus on the company's long-term performance under new CEO Greg Abel.

Axe note: Warren Buffett plans to donate his entire Berkshire Hathaway stake by 2034, a move unlikely to shake the market.